Abiopharma

Electra Provides Construction Progress Update on North America’s Only Cobalt Sulfate Refinery

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting

Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"

Arcos Dorados Reports Fourth Quarter and Full Year 2025 Financial Results

Northern York County Regional Police Becomes First in State to Deploy WrapTactics LMS, Expands BolaWrap Non-Lethal Response Capabilities

Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinsons Disease Study

Biohavens Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment

AlphaTON Capital Acquires Controlling Interest in GAMEE, Adding 119 Million Users to its Telegram Ecosystem Portfolio

KANZHUN LIMITED Announces Shareholder Return Target Through Dividend Distribution and Extension and Upsizing of Share Repurchase Program